Effects of N-methyl-D-aspartate receptor antagonists on reinforced and nonreinforced responding for ethanol in rats

Alcohol

Volumn 18, Issue 2-3, 1999, Pages 131-137

  Bienkowski, Przemyslaw ^a   Koros, Eliza ^a   Kostowski, Wojciech ^a,b   Danysz, Wojciech ^c  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Ethanol craving; Ethanol self administration; Glycine(B) site antagonists; MRZ 2 576; MRZ 2 579; Rat; Uncompetitive NMDA receptor antagonists

Indexed keywords

ALCOHOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; RAT; REINFORCEMENT; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CYCLOPENTANES; DRINKING; ETHANOL; MALE; MOTOR ACTIVITY; PHTHALAZINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY);

EID: 0032787789     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(98)00075-5     Document Type: Article

References (29)

1. A and NMDA receptor antagonists on ethanol-induced behavioral sleep in rats. Alcohol. 14:1997;167-173.
2. Bespalov A., Zvartau E. NMDA receptor antagonists prevent conditioned activation of intracranial self-stimulation in rats. Eur. J. Pharmacol. 326:1997;109-112.
3. Bienkowski P., Stefanski R., Kostowski W. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol. Eur. J. Pharmacol. 314:1996;277-280.
4. Bienkowski P., Koros E., Piasecki J., Kostowski W. Interactions of ethanol with nicotine, dizocilpine, CGP 40116, and 1-m-chlorophenyl-biguanide in rats. Pharmacol. Biochem. Behav. 58:1997;1159-1165.
5. B sites) in the discriminative stimulus effects of ethanol in the rat. Alcohol. 15:1998;87-91.
6. Bouton M.E., Swartzentruber D. Sources of relapse after extinction in Pavlovian and instrumental learning. Clin. Psychol. Rev. 11:1991;123-140.
7. Cox J., Westbrook R.F. The NMDA receptor antagonist, MK-801, blocks acquisition and extinction of conditioned hypoalgesic response in the rat. Q. J. Exp. Psychol. 47:1994;187-210.
8. Danysz W., Dyr W., Jankowska E., Glazewski S., Kostowski W. The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol. Clin. Exp. Res. 16:1992;499-504.
9. B antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids. 14:1998;235-239.
10. De Beun R., Schneider R., Klein A., Lohman A., Schreiber R., De Vry J. The calcium channel agonist BAY k 8644 reduces ethanol intake and preference in alcohol-preferring AA rats. Psychopharmacology. 127:1996;302-310.
11. Faingold C.L., N'Gouemo P., Riaz A. Ethanol and neurotransmitter interactions - From molecular to integrative effects. Prog. Neurobiol. 55:1998;509-535.
12. Files F.J., Denning C.E., Hyytia P., Kiianmaa K., Samson H.H. Ethanol-reinforced responding by AA and ANA rats following the sucrose-substitution initiation procedure. Alcohol. Clin. Exp. Res. 21:1997;749-753.
13. Grant K.A., Knisely J.S., Tabakoff B., Barrett J.E., Balster R.L. Ethanol-like discriminative stimulus effects of noncompetitive N-methyl-D-aspartate antagonists. Behav. Pharmacol. 2:1991;87-91.
14. Heyser C.J., Schulteis G., Koob G.F. Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcohol. Clin. Exp. Res. 21:1997;784-791.
15. Hoffman P.L., Tabakoff B. Alcohol dependence. A commentary on mechanisms Alcohol Alcohol. 31:1996;333-340.
16. Karcz-Kubicha M., Jessa M., Nazar M., Plaznik A., Hartmann S., Parsons C.G., Danysz W. Anxiolytic activity of glycine-B antagonists and partial agonists - No relation to intrinsic activity in the patch clamp. Neuropharmacology. 36:1997;1355-1367.
17. Kretschmer B.D. Ligands of the NMDA receptor-associated glycine recognition site and motor behavior. Amino Acids. 14:1998;227-234.
18. Krystal J.H., Petrakis I.L., Webb E., Cooney N.L., Karper L.P., Namanworth S., Stetson P., Trevisan L.A., Charney D.S. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch. Gen. Psychiatry. 55:1998;354-360.
19. Lovinger D. Alcohols and neurotransmitter gated ion channels. Naunyn Schmiedebergs Arch. Pharmakol. 356:1997;267-282.
20. Markou A., Weiss F., Gold L.H., Caine S.B., Schulteis G., Koob G.F. Animal models of craving. Psychopharmacology. 112:1993;163-182.
21. Parsons, C. G.; Danysz, W.; Bartmann, A.; Spielmanns, P.; Frankiewicz, T.; Hesselink, M.; Eilbacher, B.; Quack, G.: Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: In vitro and in vivo characterization. Neuropharmacology (in press).
22. Parsons C.G., Danysz W., Quack G., Hartmann S., Lorenz B., Wollenburg C., Baran L., Przegalinski E., Kostowski W., Krzascik P., Chizh B., Headley P.M. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor. Electrophysiological, biochemical and behavioral characterization J. Pharmacol. Exp. Ther. 283:1997;1264-1275.
23. Piasecki J., Koros E., Dyr W., Kostowski W., Danysz W., Bienkowski P. Ethanol-reinforced behavior in the rat. Effects of uncompetitive NMDA receptor antagonist, memantine Eur. J. Pharmacol. 354:1998;135-143.
24. 2+ channel inhibitor, Goe 5438. Psychopharmacology. 107:1992;447-452.
25. Rezvani A.H., Janowsky D.S. Decreased alcohol consumption by verapamil in alcohol-preferring rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 14:1990;623-631.
26. Samson H.H. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol. Clin. Exp. Res. 10:1986;436-442.
27. Shelton K.L., Balster R.L. Effects of γ-aminobutyric acid agonists and N-methyl-D-aspartate antagonists on a multiple schedule of ethanol and saccharin self-administration. J. Pharmacol. Exp. Ther. 280:1997;1250-1260.
28. Tiffany S.T. New perspectives on the measurement, manipulation and meaning of drug craving. Hum. Psychopharmacol. Clin. Exp. 12:1997;S110-S113.
29. Wenk G.L., Baker L.M., Stoehr J.D., Hauss-Wegrzyniak B., Danysz W. Neuroprotection by novel antagonists at the NMDA receptor channel and glycine(B) sites. Eur. J. Pharmacol. 347:1998;183-187.